Erlotinib is an oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) and is indicated for the treatment of non-small cell lung cancer and advanced pancreatic cancer.… Read more






![Chemical structure of Acetic acid, 2-[2-[[4-[(3-ethynylphenyl)amino]-7-(2-hydroxyethoxy)-6-quinazolinyl]oxy]ethoxy]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2218487-28-4-Acetic-acid-2-2-4-3-ethynylphenylamino-7-2-hydroxyethoxy-6-quinazolinyloxyethoxy.png&w=3840&q=75)







































Erlotinib is an oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) and is indicated for the treatment of non-small cell lung cancer and advanced pancreatic cancer. This category offers an extensive selection of high-quality reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for essential analytical tasks, including impurity profiling, forced degradation studies, and rigorous method validation. Stable isotope-labelled analogues are frequently employed as internal standards in mass spectrometry-based assays to ensure precise quantification and reproducible results in complex matrices. By serving as critical benchmarks for identity, purity, and concentration, these standards support quality control and regulatory compliance, ensuring that all pharmaceutical products meet the necessary safety and efficacy benchmarks throughout their development and manufacturing lifecycle.